Clinical trial for Type 2 Diabetes
Official title Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes
ClinicalTrials.gov ID: NCT06279637
What this study is testing
- What it's testing
- The study wants to find out if a home‑based phone program that teaches diabetes care, helps solve social problems, and encourages activity can improve patients’ blood sugar, blood pressure, cholesterol, and quality of life, and also help caregivers feel better and less burdened.
- Who it's for
- Older African American adults with type 2 diabetes who have poorly controlled blood sugar and an informal caregiver who can participate in phone calls.
- What's involved
- Participants will receive a series of phone calls that include diabetes education, problem‑solving for social needs, and activity encouragement. They will also have routine medical check‑ups and blood tests as usual care.
- Time commitment
- The study lasts about 6 months, with regular phone sessions and medical visits as needed, and involves 100 patient/caregiver pairs split between the program and usual care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 120
You may be able to join if
- Patient
- Age ≥50 years of age;
- Self-identified as Black/African American;
- Clinical diagnosis of T2DM and poorly controlled, defined as HbA1c ≥8% at the screening visit;
- Able to communicate in English; and
You likely can't join if
- Mental confusion at screening assessment suggesting significant dementia;
- Alcohol or drug abuse/dependency at screening assessment;
- Active psychosis or acute mental disorder at screening assessment; and
- Life expectancy \<6 months at screening.
See the full eligibility criteria
- Patient
- Age ≥50 years of age;
- Self-identified as Black/African American;
- Clinical diagnosis of T2DM and poorly controlled, defined as HbA1c ≥8% at the screening visit;
- Able to communicate in English; and
- Has an informal caregiver (family member or close friend willing to participate in the study for 6 months. Caregiver
- Willing to attend 4, one-hour sessions with the study participant;
- Willing to support the study participant for study duration (6 months); and
- Willing to complete brief baseline, 3- and 6-month assessments. Patient/Caregiver
- Mental confusion at screening assessment suggesting significant dementia;
- Alcohol or drug abuse/dependency at screening assessment;
- Active psychosis or acute mental disorder at screening assessment; and
- Life expectancy \<6 months at screening.
The study team makes the final eligibility decision.
Where it is enrolling
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 120 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Milwaukee, Wisconsin, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.